Continuous Wireless Vital Parameter Monitoring
Conditions
Brief summary
For patients admitted to the medical ward, it is often difficult to predict if their clinical condition will deteriorate, however subtle changes in vital signs are usually present 8 to 24 hours before a life-threatening event such as respiratory failure leading to ICU admission, or unanticipated cardiac arrest. Such adverse trends in clinical observations can be missed, misinterpreted or not appreciated as urgent. New continuous and wearable 24/7 clinical vital parameter monitoring systems offer a unique possibility to identify clinical deterioration before patients condition progress beyond the point-of-no-return, where adverse events are inevitable. The WARD project aims to determine the correlation between cardiopulmonary micro events and clinical adverse events during the first four days after hospital admission.
Interventions
DEVICEWireless continuous vital parameter monitoring
The patients included in this study will have continuous, wireless monitoring of vital parameters during the first four days of acute admission
Sponsors
Technical University of Denmark
Bispebjerg Hospital
Rigshospitalet, Denmark
University Hospital Bispebjerg and Frederiksberg
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adults \>18 years * Acute hospitalization or discharge from Intensive Care Unit (ICU) after an admission of at least 24 hours. * Early Warning Score (EWS) ≥4 at least once from admission and until inclusion * One of the following tentative diagnoses as the primary reason for admission: Pneumonia, Dyspnea, Acute myocardial infarction, heartfailure or sepsis * Inclusion conversation possible within 12 hours of admission or discharge from ICU
Exclusion criteria
* Patients that cannot cooperate * Patients that cannot give informed consent * Patients with EWS≥4 that is not of presumed physical origin * Patients with allergies to plaster or silicone * Patients with pacemaker or ICD * Patients with treatment limitations (no resuscitation or no admission to ICU) * Patients with expected discharge within 24 hours * Patients that have been included in the WARD-COPD study (H-18026653)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Serious desaturation | more than 10 minutes, within the first four days of acute admission | SpO2 \<85% in 10 consecutive minutes |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| tachycardia | one minute within the first four days of admission | Heartrate \>130/min |
| bradycardia | one minute within the first four days of admission | heartrate \>41/min |
| tachypnea | one minute within the first four days of admission | Respiration rate \>24/min |
| desaturation | more than 60 minutes, within the first four days of acute admission | SpO2 \<92% in 60 consecutive minutes |
| hypotension | one measurement within the first four days of admission | Systolic blood pressure \<90 mmHg |
| hypertension | one measurement wihtin the first four days of admission | systolic blood pressure \>219 mmHg |
| bradypnea | one minute within the first four days of admission | Respiration rate \<9/min |
Outcome results
None listed